Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003286970 | SCV003967381 | uncertain significance | Inborn genetic diseases | 2023-04-18 | criteria provided, single submitter | clinical testing | The c.640C>T (p.H214Y) alteration is located in exon 6 (coding exon 6) of the EDARADD gene. This alteration results from a C to T substitution at nucleotide position 640, causing the histidine (H) at amino acid position 214 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |